{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:29:48Z","timestamp":1788830988467,"version":"build-2803163510"},"reference-count":38,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2015,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The molecular basis of sulfadoxine-pyrimethamine (SP) resistance lies in a combination of single-nucleotide polymorphisms (SNPs) in two genes coding for\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Plasmodium falciparum<\/jats:named-content>\n            dihydrofolate reductase (\n            <jats:italic>Pfdhfr<\/jats:italic>\n            ) and\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">P. falciparum<\/jats:named-content>\n            dihydropteroate synthase (\n            <jats:italic>Pfdhps<\/jats:italic>\n            ), targeted by pyrimethamine and sulfadoxine, respectively. The continued use of SP for intermittent preventive treatment in pregnant women in many African countries, despite SP's discontinuation as a first-line antimalarial treatment option due to high levels of drug resistance, may further increase the prevalence of SP-resistant parasites and\/or lead to the selection of new mutations. An antimalarial drug resistance surveillance study was conducted in western Kenya between 2010 and 2013. A total of 203 clinical samples from children with uncomplicated malaria were genotyped for SNPs associated with SP resistance. The prevalence of the triple-mutant\n            <jats:italic>Pfdhfr<\/jats:italic>\n            C\n            <jats:sub>50<\/jats:sub>\n            <jats:bold>\n              I\n              <jats:sub>51<\/jats:sub>\n              R\n              <jats:sub>59<\/jats:sub>\n              N\n              <jats:sub>108<\/jats:sub>\n            <\/jats:bold>\n            I\n            <jats:sub>164<\/jats:sub>\n            genotype and the double-mutant\n            <jats:italic>Pfdhps<\/jats:italic>\n            S\n            <jats:sub>436<\/jats:sub>\n            <jats:bold>\n              G\n              <jats:sub>437<\/jats:sub>\n              E\n              <jats:sub>540<\/jats:sub>\n            <\/jats:bold>\n            A\n            <jats:sub>581<\/jats:sub>\n            A\n            <jats:sub>613<\/jats:sub>\n            genotype was high. Two triple-mutant\n            <jats:italic>Pfdhps<\/jats:italic>\n            genotypes, S\n            <jats:sub>436<\/jats:sub>\n            <jats:bold>\n              G\n              <jats:sub>437<\/jats:sub>\n              E\n              <jats:sub>540<\/jats:sub>\n              G\n              <jats:sub>581<\/jats:sub>\n            <\/jats:bold>\n            A\n            <jats:sub>613<\/jats:sub>\n            and\n            <jats:bold>\n              H\n              <jats:sub>436<\/jats:sub>\n              G\n              <jats:sub>437<\/jats:sub>\n              E\n              <jats:sub>540<\/jats:sub>\n            <\/jats:bold>\n            A\n            <jats:sub>581<\/jats:sub>\n            A\n            <jats:sub>613<\/jats:sub>\n            , were found, with the latter thus far being uniquely found in western Kenya. The prevalence of the S\n            <jats:sub>436<\/jats:sub>\n            <jats:bold>\n              G\n              <jats:sub>437<\/jats:sub>\n              E\n              <jats:sub>540<\/jats:sub>\n              G\n              <jats:sub>581<\/jats:sub>\n            <\/jats:bold>\n            A\n            <jats:sub>613<\/jats:sub>\n            genotype was low. However, a steady increase in the prevalence of the\n            <jats:italic>Pfdhps<\/jats:italic>\n            triple-mutant\n            <jats:bold>\n              H\n              <jats:sub>436<\/jats:sub>\n              G\n              <jats:sub>437<\/jats:sub>\n              E\n              <jats:sub>540<\/jats:sub>\n            <\/jats:bold>\n            A\n            <jats:sub>581<\/jats:sub>\n            A\n            <jats:sub>613<\/jats:sub>\n            genotype has been observed since its appearance in early 2000. Isolates with these genotypes shared substantial microsatellite haplotypes with the most common double-mutant allele, suggesting that this triple-mutant allele may have evolved locally. Overall, these findings show that the prevalence of the\n            <jats:bold>\n              H\n              <jats:sub>436<\/jats:sub>\n              G\n              <jats:sub>437<\/jats:sub>\n              E\n              <jats:sub>540<\/jats:sub>\n            <\/jats:bold>\n            A\n            <jats:sub>581<\/jats:sub>\n            A\n            <jats:sub>613<\/jats:sub>\n            triple mutant may be increasing in this population and could compromise the efficacy of SP for intermittent preventive treatment in pregnant women if it increases the resistance threshold further.\n          <\/jats:p>","DOI":"10.1128\/aac.04961-14","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T02:31:49Z","timestamp":1429583509000},"page":"3995-4002","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":17,"title":["Increasing Prevalence of a Novel Triple-Mutant Dihydropteroate Synthase Genotype in Plasmodium falciparum in Western Kenya"],"prefix":"10.1128","volume":"59","author":[{"given":"Naomi W.","family":"Lucchi","sequence":"first","affiliation":[{"name":"Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila Akinyi","family":"Okoth","sequence":"additional","affiliation":[{"name":"Atlanta Research and Education Foundation, Decatur, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Komino","sequence":"additional","affiliation":[{"name":"Kenya Medical Research Institute-Centers for Disease Control and Prevention Collaboration, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Onyona","sequence":"additional","affiliation":[{"name":"Kenya Medical Research Institute-Centers for Disease Control and Prevention Collaboration, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira F.","family":"Goldman","sequence":"additional","affiliation":[{"name":"Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Ljolje","sequence":"additional","affiliation":[{"name":"Atlanta Research and Education Foundation, Decatur, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya Ping","family":"Shi","sequence":"additional","affiliation":[{"name":"Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Barnwell","sequence":"additional","affiliation":[{"name":"Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatachalam","family":"Udhayakumar","sequence":"additional","affiliation":[{"name":"Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Kariuki","sequence":"additional","affiliation":[{"name":"Kenya Medical Research Institute-Centers for Disease Control and Prevention Collaboration, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-247"},{"key":"e_1_3_2_3_2","volume-title":"Report of the technical consultation on intermittent preventive treatment in infants (IPTi)","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. 2009. Report of the technical consultation on intermittent preventive treatment in infants (IPTi). Technical Expert Group on Preventive Chemotherapy, World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182097001261"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.12028"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2013.08.002"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-250"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1368-7646(98)80014-9"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004569"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/504687"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-134"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00623-08"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000055"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.13-0214"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir376"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1909.130133"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2007.131720"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-338"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2013.07.008"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1098876"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir664"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000830"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq038"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-77"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01677-08"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.2004.3026"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-9525(02)00012-4"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5443.1351"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-6-72"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-177"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4269\/ajtmh.2009.80.523","article-title":"Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene","volume":"80","author":"Alifrangis M","year":"2009","unstructured":"Alifrangis M, Lusingu JP, Mmbando B, Dalgaard MB, Vestergaard LS, Ishengoma D, Khalil IF, Theander TG, Lemnge MM, Bygbjerg IC. 2009. Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene. Am J Trop Med Hyg 80:523\u2013527.","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2008.01.018"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2004.07.002"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1994.00397.x"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.15.7149"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2006.02.035"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0901415106"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056183"},{"key":"e_1_3_2_40_2","volume-title":"Intermittent preventive treatment (IPT) of malaria in pregnancy","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. 2013. Intermittent preventive treatment (IPT) of malaria in pregnancy. Evidence Review Group, World Health Organization, Geneva, Switzerland."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.04961-14","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.04961-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:53:47Z","timestamp":1645484027000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.04961-14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1128\/AAC.04961-14"],"URL":"https:\/\/doi.org\/10.1128\/aac.04961-14","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"2015-01-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-04-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-06-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}